Free Trial
NASDAQ:MTSR

Metsera (MTSR) Stock Price, News & Analysis

Metsera logo
$32.35 +2.23 (+7.40%)
As of 10:50 AM Eastern

About Metsera Stock (NASDAQ:MTSR)

Key Stats

Today's Range
$30.28
$33.05
50-Day Range
$22.74
$35.10
52-Week Range
$12.30
$37.99
Volume
255,036 shs
Average Volume
904,229 shs
Market Capitalization
$3.40 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$55.00
Consensus Rating
Buy

Company Overview

Receive MTSR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Metsera and its competitors with MarketBeat's FREE daily newsletter.

MTSR Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
See More Headlines

MTSR Stock Analysis - Frequently Asked Questions

Metsera's stock was trading at $29.50 at the beginning of 2025. Since then, MTSR stock has increased by 5.9% and is now trading at $31.25.

Metsera Inc. (NASDAQ:MTSR) issued its quarterly earnings results on Monday, May, 12th. The company reported ($1.03) EPS for the quarter.

Metsera (MTSR) raised $275 million in an IPO on Friday, January 31st 2025. The company issued 15,277,778 shares at a price of $18.00 per share.

Metsera's lock-up period expires on Wednesday, July 30th. Metsera had issued 15,277,778 shares in its public offering on January 31st. The total size of the offering was $275,000,004 based on an initial share price of $18.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the expiration of the lock-up period.

Shares of MTSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/12/2025
Today
7/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MTSR
Previous Symbol
NASDAQ:MTSR
CIK
2040807
Web
N/A
Fax
N/A
Employees
81
Year Founded
N/A

Price Target and Rating

High Price Target
$65.00
Low Price Target
$38.00
Potential Upside/Downside
+82.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($2.46) per share
Price / Book
-12.24

Miscellaneous

Free Float
N/A
Market Cap
$3.16 billion
Optionable
N/A
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:MTSR) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners